Salflumix Easyhaler (Salmeterol / Fluticasone)
Combination inhaler for long-term asthma and COPD management
Quick facts about Salflumix Easyhaler
Key takeaways about Salflumix Easyhaler
- Not a rescue inhaler: Salflumix Easyhaler is a maintenance medication – always carry a separate short-acting bronchodilator (e.g., salbutamol) for sudden breathing problems
- Take it daily: Use every day as prescribed, even when you feel well, to maintain asthma or COPD control
- Rinse your mouth after use: Rinsing with water and spitting out after each dose significantly reduces the risk of oral thrush and hoarseness
- Never stop suddenly: Abruptly stopping can worsen symptoms and in rare cases cause adrenal insufficiency – always consult your doctor first
- Shake-Click-Inhale technique: The Easyhaler device requires a specific 3-step technique for correct dosing – proper technique is essential for treatment effectiveness
What Is Salflumix Easyhaler and What Is It Used For?
Salflumix Easyhaler is a combination inhaler that contains two active substances: salmeterol, a long-acting beta-2 agonist (LABA) that keeps the airways open for at least 12 hours, and fluticasone propionate, an inhaled corticosteroid (ICS) that reduces inflammation and swelling in the lungs. It is used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD).
Salflumix Easyhaler belongs to a class of medications known as combination inhalers. These combination products deliver two complementary therapies in a single device, improving both treatment adherence and clinical outcomes. The salmeterol component works by relaxing the smooth muscle surrounding the airways, causing them to widen and making it easier to breathe. This bronchodilator effect lasts for at least 12 hours after each inhalation, providing sustained relief from bronchoconstriction throughout the day and night.
The fluticasone propionate component is a potent inhaled corticosteroid that acts locally within the lungs to reduce airway inflammation, mucus production, and bronchial hyperresponsiveness. By decreasing the underlying inflammatory process, fluticasone helps prevent asthma attacks and COPD exacerbations from occurring. Unlike systemic corticosteroids taken as tablets, inhaled fluticasone works predominantly within the lungs, which significantly reduces the risk of systemic side effects when used at recommended doses.
Your doctor may prescribe Salflumix Easyhaler for the prevention of breathing difficulties in the following conditions:
- Asthma in adults and adolescents aged 12 years and older – when treatment with both a long-acting bronchodilator and an inhaled corticosteroid is appropriate. This is typically recommended when asthma is not adequately controlled with an inhaled corticosteroid alone, or when the combination of both medications is justified based on disease severity.
- Chronic obstructive pulmonary disease (COPD) in adults – specifically, the Salflumix Easyhaler 50/500 mcg strength is indicated to reduce the number and severity of COPD exacerbations (flare-ups) in patients with a history of frequent exacerbations despite regular bronchodilator therapy.
Salflumix Easyhaler prevents breathing difficulties and wheezing but should never be used to relieve a sudden asthma attack or acute breathlessness. If you experience sudden symptoms, use a separate short-acting rescue inhaler such as salbutamol (albuterol). Always carry your rescue inhaler with you.
Salflumix Easyhaler must be taken every day as directed by your doctor to work effectively. Even if you feel well and have no symptoms, it is essential to continue your daily doses. The corticosteroid component takes time to build its full anti-inflammatory effect, and stopping treatment prematurely can lead to a loss of asthma or COPD control, potentially resulting in serious flare-ups. According to the Global Initiative for Asthma (GINA) guidelines, regular use of a LABA/ICS combination in appropriate patients leads to improved symptom control, reduced exacerbation rates, and better quality of life compared to using either component alone.
What Should You Know Before Taking Salflumix Easyhaler?
Before using Salflumix Easyhaler, tell your doctor about all medical conditions you have, particularly heart disease, diabetes, thyroid problems, or low potassium levels. You should not use this medicine if you are allergic to salmeterol, fluticasone propionate, or lactose (which contains small amounts of milk protein).
Contraindications
Do not take Salflumix Easyhaler if you are allergic (hypersensitive) to salmeterol, fluticasone propionate, or to the excipient lactose monohydrate. The lactose excipient contains small amounts of milk protein, which may cause allergic reactions in individuals with a milk protein allergy. Note that lactose intolerance is different from milk protein allergy – the small amount of lactose present (up to 17.1 mg per dose) does not normally cause problems in people who are lactose intolerant.
Warnings and Precautions
Talk to your doctor before using Salflumix Easyhaler if you have any of the following conditions, as additional monitoring or dose adjustments may be necessary:
- Heart disease – including rapid or irregular heartbeat (arrhythmia). Salmeterol can occasionally cause cardiac effects, particularly at higher doses or in patients with pre-existing cardiovascular conditions. Your doctor may wish to monitor your heart rhythm closely.
- Overactive thyroid gland (hyperthyroidism) – thyroid hormones can enhance the cardiovascular effects of beta-2 agonists like salmeterol, potentially increasing heart rate and causing palpitations.
- High blood pressure (hypertension) – salmeterol may occasionally raise blood pressure, so regular monitoring is advised, especially during the initial treatment period.
- Diabetes mellitus – Salflumix Easyhaler may increase blood sugar levels. If you have diabetes, you may need to check your blood glucose more frequently and your diabetes treatment may require adjustment.
- Low potassium levels (hypokalemia) – beta-2 agonists and corticosteroids can both lower potassium levels. Your doctor may order periodic blood tests to monitor your potassium, especially if you are also taking other medications known to reduce potassium (such as diuretics or theophylline).
- History of tuberculosis (TB) or other lung infections – corticosteroids suppress local immune function, which could theoretically reactivate latent TB or increase susceptibility to new lung infections. Make sure to inform your doctor if you have ever had TB.
Contact your doctor if you experience blurred vision or other visual disturbances while using Salflumix Easyhaler, as these may be signs of cataracts or glaucoma, which are rare side effects of long-term inhaled corticosteroid use.
Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before using Salflumix Easyhaler. Your doctor will weigh the benefits of the treatment against any potential risks to you and your baby. Both GINA and the European Medicines Agency (EMA) acknowledge that maintaining good asthma control during pregnancy is essential, as uncontrolled asthma poses greater risks to both mother and baby than the use of inhaled medications. Do not stop your asthma treatment during pregnancy without medical advice.
Driving and Operating Machinery
Salflumix Easyhaler is unlikely to affect your ability to drive or use machinery. However, you should be aware of your overall condition and any side effects you may experience. If you feel dizzy, shaky, or have blurred vision, do not drive or operate machinery until these effects have resolved.
How Does Salflumix Easyhaler Interact with Other Drugs?
Salflumix Easyhaler can interact with several types of medications. Beta-blockers should generally be avoided. Strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, ritonavir, and cobicistat) can significantly increase fluticasone levels in the body, raising the risk of systemic corticosteroid side effects. Always tell your doctor about all medications you take.
Drug interactions can alter how Salflumix Easyhaler works or increase the risk of side effects. It is important to tell your doctor or pharmacist about all medicines you are taking, including prescription medications, over-the-counter products, and herbal supplements. The following table summarises the most clinically significant interactions:
| Interacting Drug | Effect | Clinical Advice |
|---|---|---|
| Beta-blockers (e.g., atenolol, propranolol, sotalol) | May reduce or block the bronchodilating effect of salmeterol, potentially worsening breathing difficulties | Generally avoid combination. If a beta-blocker is essential, cardioselective options are preferred under close medical supervision |
| Ketoconazole, Itraconazole (antifungals) | Strong CYP3A4 inhibitors – significantly increase fluticasone and salmeterol levels, raising risk of systemic corticosteroid effects and cardiac side effects | Avoid concurrent use if possible. If unavoidable, use with extreme caution under careful monitoring |
| Ritonavir, Cobicistat (HIV antivirals) | Potent CYP3A4 inhibitors – markedly increase fluticasone exposure, risking Cushing syndrome and adrenal suppression | Concurrent use is not recommended unless the benefit outweighs the risk. Close monitoring for systemic corticosteroid effects is essential |
| Erythromycin (macrolide antibiotic) | Moderate CYP3A4 inhibitor – may increase fluticasone and salmeterol levels | Monitor for increased side effects including irregular heartbeat |
| Systemic corticosteroids (e.g., prednisolone, dexamethasone) | Additive risk of adrenal suppression, especially during transition from oral to inhaled corticosteroids | Gradual dose reduction of systemic corticosteroid is recommended. Monitor for signs of adrenal insufficiency |
| Diuretics (e.g., furosemide, hydrochlorothiazide) | Both salmeterol and diuretics can lower potassium levels, increasing risk of hypokalemia | Monitor potassium levels regularly. Consider potassium supplementation if needed |
| Xanthine derivatives (e.g., theophylline) | Additive hypokalemia risk and potential for increased cardiac stimulation | Monitor serum potassium and heart rhythm. Adjust doses as necessary |
| Other LABAs (e.g., formoterol) | Additive beta-2 agonist effects – risk of tachycardia, tremor, and hypokalemia | Avoid concurrent use of two long-acting bronchodilators |
This list is not exhaustive. Always inform your healthcare provider about all medications, supplements, and herbal products you use before starting Salflumix Easyhaler or any new treatment. Some interactions are manageable with appropriate monitoring, while others may require an alternative medication.
What Is the Correct Dosage of Salflumix Easyhaler?
The usual dose is 1 inhalation twice daily (morning and evening) for both asthma and COPD. The strength prescribed depends on your condition and severity. Salflumix Easyhaler is not recommended for children under 12 years of age. Always follow your doctor's instructions regarding the number of inhalations and dosing frequency.
Always use Salflumix Easyhaler exactly as your doctor or pharmacist has instructed. The medication is inhaled through the mouth into the lungs using the Easyhaler dry powder inhaler device. The correct strength and dosing schedule will be determined by your doctor based on the severity of your condition and your individual response to treatment.
Adults and Adolescents (12 Years and Older) – Asthma
Salflumix Easyhaler 50/250 mcg
1 inhalation twice daily (morning and evening). This strength is appropriate for patients with moderate asthma requiring both a LABA and a moderate-dose ICS.
Salflumix Easyhaler 50/500 mcg
1 inhalation twice daily (morning and evening). This higher strength is for patients with more severe asthma who require a higher dose of inhaled corticosteroid.
Adults – COPD
Salflumix Easyhaler 50/500 mcg
1 inhalation twice daily (morning and evening). Only the 50/500 mcg strength is indicated for COPD. If your symptoms are well controlled on twice-daily dosing, your doctor may consider reducing to 1 inhalation once daily – either in the morning (if you have daytime symptoms) or in the evening (if you have nighttime symptoms).
Children Under 12 Years
Salflumix Easyhaler is not recommended for children under 12 years of age. Your doctor will prescribe alternative treatments suitable for younger patients.
| Indication | Strength | Dose | Frequency |
|---|---|---|---|
| Asthma (moderate) | 50/250 mcg | 1 inhalation | Twice daily |
| Asthma (severe) | 50/500 mcg | 1 inhalation | Twice daily |
| COPD | 50/500 mcg | 1 inhalation | Twice daily (may reduce to once daily if well controlled) |
It is very important to follow your doctor's instructions regarding the correct number of inhalations and dosing frequency. If you are using Salflumix Easyhaler for asthma, your doctor will review your symptoms regularly and may adjust your treatment accordingly. Contact your doctor immediately if your asthma or breathing worsens – for example, if your breathing becomes more wheezy, you feel increasing chest tightness, or you need to use your rescue inhaler more often. Continue using Salflumix Easyhaler as prescribed but do not increase the number of doses without medical advice.
Missed Dose
If you forget to take a dose, take the next dose at the regular time. Do not take a double dose to make up for a missed one. Consistency is important for optimal treatment effect, so try to take your doses at the same times each day.
Overdose
If you accidentally take more than the recommended dose, contact your doctor or pharmacist. You may notice your heart beating faster than usual, trembling, headache, muscle weakness, or joint pain. If you have taken significantly more than the prescribed amount over a prolonged period, seek medical attention promptly, as excessive doses of fluticasone can suppress adrenal gland function.
It is essential to continue taking Salflumix Easyhaler every day until your doctor advises you to stop. Never stop or reduce your dose abruptly. Sudden discontinuation may worsen your symptoms and can, in rare cases, lead to adrenal insufficiency – a potentially serious condition where the body cannot produce enough cortisol. Symptoms of adrenal insufficiency can include stomach pain, fatigue, loss of appetite, nausea, low blood sugar, low blood pressure, and seizures. If you need to stop treatment, your doctor will guide you through a gradual dose reduction.
How Do You Use the Salflumix Easyhaler Correctly?
The Easyhaler uses a simple 3-step technique: Shake, Click, Inhale. Correct inhaler technique is crucial for getting the right dose of medication into your lungs. After each use, rinse your mouth with water and spit it out to reduce the risk of oral thrush.
The Salflumix Easyhaler may differ from inhalers you have used before. Using it incorrectly can mean you receive too little medication, which may worsen your condition. Your doctor, nurse, or pharmacist should demonstrate the correct technique. Each inhaler contains 60 doses and has a built-in dose counter that counts down with every fifth dose. When the counter turns red (20 doses remaining), arrange a new prescription.
Step 1: Shake
Remove the protective cap from the mouthpiece. Hold the inhaler upright and shake it 3 to 5 times. It is important to keep the inhaler in an upright position during shaking. If you accidentally click the inhaler while shaking, tap the mouthpiece to empty any released powder, and start again from Step 1.
Step 2: Click
Hold the Easyhaler upright between your index finger and thumb. Press the top of the device once until you hear a click, then release. This loads exactly one dose. Press only once – if you accidentally click more than once, tap the mouthpiece to remove the excess powder and start again. It is important to click before you inhale, not simultaneously. Keep the inhaler upright; if you tilt it, the powder may fall out before you can inhale it.
Step 3: Inhale
Continue holding the inhaler upright. Breathe out normally (away from the inhaler – do not breathe into the mouthpiece as this can block it). Place the mouthpiece in your mouth between your teeth and close your lips tightly around it. Inhale deeply and forcefully through your mouth. Remove the inhaler from your mouth, hold your breath for at least 5 seconds, and then breathe out normally.
After Use
Replace the protective cap on the mouthpiece to prevent accidental dosing. Rinse your mouth with water and spit it out, and/or brush your teeth after each use. This significantly reduces the risk of developing oral thrush (candidiasis) and hoarseness. Keep the inhaler dry and clean – if it needs cleaning, wipe the mouthpiece with a dry cloth. Never use water, as the powder is moisture-sensitive.
What Are the Side Effects of Salflumix Easyhaler?
Like all medicines, Salflumix Easyhaler can cause side effects, although not everyone experiences them. Common side effects include headache, oral thrush, hoarseness, and muscle cramps. Serious allergic reactions are uncommon. Your doctor will prescribe the lowest effective dose to minimise the risk of side effects.
The following side effects have been reported with Salflumix Easyhaler. Your doctor has weighed the benefits of this medicine against the risk of side effects when prescribing it to you. Most side effects are mild to moderate and may improve as your body adjusts to the treatment.
Sudden difficulty breathing, wheezing, or worsening of symptoms immediately after taking Salflumix Easyhaler; hives, swelling of the face, lips, tongue or throat; rapid or very slow heartbeat; or feeling faint or collapsing. These may be signs of a serious allergic reaction or paradoxical bronchospasm. Stop using the inhaler and call emergency services immediately.
If you have COPD and are using Salflumix Easyhaler, tell your doctor if you develop fever or chills, increased sputum production, change in sputum colour, worsening cough, or increased breathing difficulty, as these may be signs of pneumonia. The risk of pneumonia is a known class effect of inhaled corticosteroids in COPD patients and is discussed in the GOLD COPD guidelines.
Very Common
- Headache – usually temporary and resolves after a few days of use
- Increased frequency of upper respiratory tract infections (colds) – reported particularly in COPD patients
Common
- Oral thrush (candidiasis) – a fungal infection causing creamy white, sore patches in the mouth and throat. Tongue irritation and hoarseness may also occur. Rinse your mouth with water after each dose to reduce this risk
- Aching, swollen joints and muscle pain
- Muscle cramps
- Bruising and bone fractures (in COPD patients)
- Sinusitis (in COPD patients)
- Decreased blood potassium levels (in COPD patients) – may cause irregular heartbeat, muscle weakness, or cramps
Uncommon
- Elevated blood glucose (hyperglycemia) – if you have diabetes, you may need more frequent blood sugar monitoring
- Cataracts (clouding of the lens in the eye)
- Very fast heartbeat (tachycardia)
- Tremor (shakiness) and palpitations – often harmless and may subside with continued use
- Chest pain
- Feeling anxious (mainly in children)
- Sleep disturbances
- Allergic skin rash
Rare
- Paradoxical bronchospasm – worsening of breathing or wheezing immediately after inhalation. If this occurs, stop using Salflumix Easyhaler, use your rescue inhaler, and contact your doctor immediately
- Effects on adrenal steroid hormone production (particularly with high doses over long periods), including: growth delay in children and adolescents, decreased bone mineral density, glaucoma, weight gain, and moon face (Cushing syndrome)
- Behavioural changes, including overactivity and irritability (mainly in children)
- Irregular heartbeat or extra heartbeats (arrhythmia)
- Oesophageal candidiasis (fungal infection of the oesophagus), which may cause difficulty swallowing
Frequency Not Known
- Depression or aggression – more likely in children
- Blurred vision
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed above. You can also report side effects directly to your national medicines regulatory authority to help contribute to ongoing drug safety monitoring.
How Should You Store Salflumix Easyhaler?
Store Salflumix Easyhaler below 25°C after opening the foil pouch. Keep it protected from moisture. Replace the 50/250 strength within 1 month and the 50/500 strength within 2 months of opening the foil pouch. Keep all medicines out of the reach and sight of children.
Proper storage ensures your medication remains effective and safe throughout its use. The following guidelines should be followed:
- Keep out of reach and sight of children – store the inhaler in a safe place inaccessible to young children.
- Check the expiry date – do not use the inhaler after the expiry date (EXP) printed on the outer carton, foil pouch, and inhaler label. The expiry date refers to the last day of the stated month.
- Do not open the foil pouch prematurely – the foil pouch helps keep the inhalation powder dry. Only open it when you are ready to start using the medicine.
- Note the opening date – write down the date you opened the foil pouch. Replace the Salflumix Easyhaler 50/250 after 1 month, or the 50/500 after 2 months from opening, even if doses remain.
- Store below 25°C after opening the foil pouch and protect from moisture. You may use a protective case with your Easyhaler to help maintain product shelf life.
- If the inhaler gets wet, replace it with a new one immediately – moisture can damage the powder formulation and affect dosing accuracy.
- Disposal – do not throw medicines into wastewater or household rubbish. Ask your pharmacist how to dispose of medicines no longer in use. This helps protect the environment.
What Does Salflumix Easyhaler Contain?
Each dose of Salflumix Easyhaler contains salmeterol xinafoate (equivalent to 50 micrograms of salmeterol) and either 250 or 500 micrograms of fluticasone propionate. The only other ingredient is lactose monohydrate, which contains small amounts of milk proteins.
The Salflumix Easyhaler is a breath-actuated dry powder inhaler. The inhalation powder is white. Each inhaler contains 60 metered doses and is a white device with a purple top. The inhaler is available in packs of 1, 2, or 3 inhalers, although not all pack sizes may be marketed in every country.
| Component | 50/250 mcg Strength | 50/500 mcg Strength |
|---|---|---|
| Salmeterol (as xinafoate) | 50 micrograms | 50 micrograms |
| Fluticasone propionate | 250 micrograms | 500 micrograms |
| Lactose monohydrate (excipient) | Up to 17.1 mg | Up to 17.1 mg |
The lactose excipient contains small amounts of milk protein. This is generally not a concern for people with lactose intolerance, but individuals with a confirmed milk protein allergy should not use this product and should discuss alternative inhalers with their doctor.
Frequently Asked Questions About Salflumix Easyhaler
Salflumix Easyhaler is a combination inhaler containing salmeterol (a long-acting bronchodilator) and fluticasone propionate (an inhaled corticosteroid). It is used for the regular treatment of asthma in adults and adolescents aged 12 years and older when a combination of a LABA and ICS is appropriate. The 50/500 strength is also approved for COPD to reduce exacerbation frequency. It is a maintenance medication and must not be used for sudden breathing problems.
No. Salflumix Easyhaler is a preventer (maintenance) inhaler, not a rescue inhaler. It should be taken regularly every day to prevent breathing difficulties. For sudden asthma attacks or acute breathlessness, you need a separate short-acting bronchodilator such as salbutamol (albuterol). Always keep your rescue inhaler with you at all times.
Follow the Shake-Click-Inhale technique: (1) Remove the cap and shake the upright inhaler 3-5 times. (2) Press the top once until you hear a click to load a dose. (3) Breathe out normally, place the mouthpiece between your teeth with lips sealed, and inhale deeply and forcefully. Hold your breath for at least 5 seconds. After use, always rinse your mouth with water and spit it out to prevent oral thrush.
The most common side effects include headache (often temporary), oral thrush (fungal infection in the mouth and throat causing white patches, soreness, and hoarseness), muscle cramps, and joint pain. Upper respiratory tract infections are also common, especially in COPD patients. Rinsing your mouth with water after every inhalation can significantly reduce the risk of oral thrush.
No. You should never stop taking Salflumix Easyhaler suddenly or reduce the dose without first talking to your doctor. Stopping abruptly can cause your asthma or COPD symptoms to worsen significantly, and in rare cases may lead to adrenal insufficiency – a condition where the body cannot produce enough cortisol on its own. Your doctor will guide you through any dose changes gradually if appropriate.
Store below 25°C after opening the foil pouch and keep it protected from moisture. Replace the 50/250 strength within 1 month and the 50/500 strength within 2 months of opening the foil pouch. If the inhaler gets wet, replace it immediately. Write down the date you open the foil pouch to help you remember when to replace the device.
References
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2024. Available at: ginasthma.org
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD, 2024. Available at: goldcopd.org
- European Medicines Agency (EMA). Summary of Product Characteristics – Salmeterol/Fluticasone propionate combination products. Available at: ema.europa.eu
- British National Formulary (BNF). Salmeterol with Fluticasone Propionate. Available at: bnf.nice.org.uk
- World Health Organization (WHO). WHO Model List of Essential Medicines, 23rd List, 2023. Available at: who.int
- Bateman ED, et al. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respiratory Research, 2011;12:38. DOI: 10.1186/1465-9921-12-38
- Calverley PMA, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New England Journal of Medicine, 2007;356(8):775-789. DOI: 10.1056/NEJMoa063070
- Cochrane Database of Systematic Reviews. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children, 2014. DOI: 10.1002/14651858.CD004106.pub5
About the Medical Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, comprising licensed specialist physicians with expertise in pulmonology, clinical pharmacology, and respiratory medicine. All content follows international medical guidelines including GINA, GOLD, EMA SmPC documentation, and WHO Essential Medicines List recommendations.
Evidence Standards
All medical claims are supported by peer-reviewed evidence rated according to the GRADE framework. Drug information is based on approved product information (SmPC/PIL) and international treatment guidelines with evidence level 1A.
Independence
iMedic receives no pharmaceutical industry funding. All editorial content is independent and free from commercial influence. Our medical information is reviewed solely on the basis of scientific evidence and clinical relevance.
Last medical review: | Published: | Meet our medical team | Editorial standards